2Hackler RH. A 25 - year prospective mortality study in the spinal cord injured patient: comparison with the long- term living paraplegic[J]. J Urol,1997,117:486 - 491.
5Wall BM, Huch KM, Mangold TA, et at. Risk factorts for development of proteinuria in chronic spinal cord injury[J]. Am J Kidney Dis, 1999,33 (5) : 8993 - 8903.
6Vaziri ND,Winer RL,Conzales EV,et al. Fibrinolytie and protease inhibitory systems in spinal cord injured patients with endstage renal disease[J]. J Am Paraplegia Sol. 1993,16(3), 149- 152.
7Van Guldener C, Stam F, Stare F, et al. Hyperhomocysteinaemia in chronic kiyney disease: focus on transmethylation[J]. Clin Chemi Lab Med,2005,43(10):1026-1031.
8Fan Yi, Pin- Lan li. Mechanisms of homocysteine- induced glomerular injury and sclerosis[J].Am J Nephrology,2008, 28(2) :254 - 264.
9Peter WF. Homocysteineand coronary heart disease how greatis the hazard? [J].JAMA,2002,288:2042 - 2043.
8NKF K/DOQI Guidelines. Guideline 3. Individuals at increased risk of chronic kidney disease.http://www. Kidney. org/professionals/kdoqi/guidelines ckd/p4_ class_g3. htm.
9NKF K/DOQI Guidelines. Guideline 13. Factors associated with loss of kidney disease, http://www, kidney, org/professionals/kdoqi/guidelines_ ckd/p7_ risk g13. htm.
10Wall BM, Huch KM, Mangold TA, et al. Risk factors for development of proteinuria in chronic spinal cord injury. Am J Kidney Dis, 1999,33(5) :8993 - 8903.
